Mutation analysis of the SMARCA4 gene revealed a unique pattern of mutations that were mutually exclusive with the most common target oncogene mutations in non-small cell lung cancer (NSCLC), such as EGFR, ALK, MET, ROS1, and RET. This finding was consistent with the genetic testing results of this patient. This evidence concerns the gene ALK and non-small cell lung carcinoma.